Navigation Links
Portola Announces Data Showing Its Anti-Platelet Drug Inhibits Platelets in Clopidogrel (Plavix(R)) Non-Responders
Date:11/12/2008

- Direct-Acting PRT060128 Provides Reversible, High-level Platelet

Inhibition with Immediate Onset of Action -

NEW ORLEANS and SOUTH SAN FRANCISCO, Calif., Nov. 12 /PRNewswire/ -- Portola Pharmaceuticals, a biopharmaceutical company developing innovative drugs that provide significant advances in cardiovascular and inflammatory diseases, and cancer, today announced new clinical data that demonstrate PRT060128, the Company's novel anti-platelet drug that directly and reversibly inhibits the P2Y12 ADP receptor, overcomes high platelet reactivity (HPR) in patients who do not respond to clopidogrel (Plavix(R)). The results [Abstract #5603] were presented at the American Heart Association (AHA) Scientific Sessions 2008 in New Orleans, LA.

Studies show there is substantial variability in patient response to clopidogrel therapy with up to 30% of patients not responding to treatment. Numerous studies link this suboptimal treatment response to poor clinical outcomes.

PRT060128 is the only reversible, direct acting, intravenous (IV) and oral ADP receptor antagonist in clinical development. Inhibiting the P2Y12 ADP receptor on platelets has been proven to prevent thrombosis and subsequent heart attacks. Portola believes that PRT060128 may provide significant clinical benefit through immediate, high-level platelet inhibition in the acute setting and a seamless transition to predictable, reversible platelet inhibition in the chronic setting.

"Of the millions of cardiac patients treated with clopidogrel anti- platelet therapy every year, a significant portion do not respond, and remain at high risk for major adverse cardiac events," said Paul A. Gurbel, M.D., principal investigator and Director of Cardiovascular Research at the Center for Thrombosis Research at Sinai Hospital, Baltimore, MD. "These results show that this direct-acting anti-platelet agent with a novel mechanism of action may have the potential to fill this sign
'/>"/>

SOURCE Portola Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Portola Announces Data Presentations Relevant to Its Lead Phase II Antithrombotic Compounds at American Heart Association Scientific Sessions 2008
2. Portola Completes $60 Million Financing to Advance Its Therapeutic Programs
3. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
4. Alba Therapeutics Announces Enrollment of Its First European Patient in Global Phase IIb Study of Larazotide Acetate for Treatment of Active Celiac Disease
5. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
6. Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring
7. Diagenic Announces Launch of First Breast Cancer Gene-Expression Blood Test
8. VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease
9. Celladon Announces Presentation of Clinical Data From First-in-Human MYDICAR(R) Trial for Advanced Heart Failure at American Heart Association Scientific Sessions
10. Poniard Pharmaceuticals Announces Final Top-Line Results from Phase 1 Trial Demonstrating Positive Bioavailability with Oral Picoplatin
11. VIA Pharmaceuticals Announces Conference Call and Webcast to Discuss VIA-2291 Phase 2 Data Presentations at AHA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... LONDON , July 31, 2014 ... for the medical industries, announced today the incorporation of genae UK ... United Kingdom has one of the largest medical device ... in 2012 and it is projected to increase by a CAGR ... billion in 2012, equal to 9.5% of GDP. Despite recessionary pressures, ...
(Date:7/31/2014)... July 31, 2014 Astellas has appointed ... corporate and employee communications in the Americas region. ... , senior vice president, chief communications officer. In ... and leading corporate brand initiatives and reputation management ... and South America . She ...
(Date:7/31/2014)... 2014 The Galien Foundation today announced the ... USA Awards. The Prix Galien Award ... the technical, scientific and clinical research skills necessary to ... brings the highest number of nominees since the inception ... Nominees include biomedical products across three categories – biotechnology, ...
Breaking Medicine Technology:genae Opens Offices in London 2Astellas Hires Industry Veteran Moyra Knight as Head of Corporate and Employee Communications 2The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 2The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 3The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 4The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 5
... , DUBLIN, Ohio , July 15 Cardinal ... LLC, expanding the company,s presence in specialty pharmaceutical services. , ... Healthcare Solutions Holding ... Pathways and P4 Healthcare. These businesses serve key participants across the ...
... , SAN MATEO, Calif. , July 15 Merz ... to doctors, offices throughout the U.S.  Previously only available in Europe ... (FDA). , , , ... study published in the June issue of Phlebology , leading experts ...
Cached Medicine Technology:Cardinal Health Completes Acquisition of Healthcare Solutions Holding 2Cardinal Health Completes Acquisition of Healthcare Solutions Holding 3Merz Aesthetics™ Asclera™ (polidocanol) Injection Now Available in Doctors' Offices Nationwide 2Merz Aesthetics™ Asclera™ (polidocanol) Injection Now Available in Doctors' Offices Nationwide 3Merz Aesthetics™ Asclera™ (polidocanol) Injection Now Available in Doctors' Offices Nationwide 4
(Date:7/31/2014)... York, NY (PRWEB) July 31, 2014 The VitalSleep ... the lower jaw forward to help open a snorers airway to ... anti-snoring remedy helped her relationship with her husband by ... am a 46 years old. My snoring began about 15 years ... my husband and children could not sleep and had to head ...
(Date:7/31/2014)... 2014 Today, Good Neighbor Pharmacy ... patient care by kicking off another year of ... first of many education sessions and initiatives took ... Good Neighbor Pharmacy and AmerisourceBergen’s annual conference. Sessions ... (CMS) Star Measures were a highlight and helped ...
(Date:7/31/2014)... Live To Be Sober , a ... guidance, advice and program information to people who want ... drug or alcohol addiction, proudly announced today that it ... country music’s bad boy, gone good. , "NBC's The ... commented Blake, whose new single Stomp (#Stomp; available on ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Clifton Dental ... the application of topical fluoride treatments to their adult ... and help with tooth sensitivity in patients that exhibit ... an infection that is commonly known as “tooth decay” ... tissues of the teeth. , Fluoride therapy ...
(Date:7/31/2014)... a novel method for creating self-assembled protein/polymer nanostructures ... cells. The work offers a promising new way ... engineering applications. The findings were published in the ... Edition . , "We have demonstrated that, by ... form completely new types of aggregates. These aggregates ...
Breaking Medicine News(10 mins):Health News:New Snoring Mouthpiece Reviews from VitalSleep 2Health News:Good Neighbor Pharmacy Reinforces Commitment to Helping Enhance Patient Care 2Health News:Good Neighbor Pharmacy Reinforces Commitment to Helping Enhance Patient Care 3Health News:Addiction Referral Service Live To Be Sober (LiveToBeSober.com) Announces Sponsorship of Jared Blake: Country Music’s Bad Boy, Gone Good 2Health News:Addiction Referral Service Live To Be Sober (LiveToBeSober.com) Announces Sponsorship of Jared Blake: Country Music’s Bad Boy, Gone Good 3Health News:NJ Top Dentists Approved, Clifton Dental Associates Now Actively Recommending the Application of Topical Fluoride Treatments to Adults 2Health News:Carnegie Mellon chemists create nanofibers using unprecedented new method 2
... Health Tax, is the Undisclosed Premium Surcharge that Pays for ... Join the Ranks of the Uninsured, the ,Hidden Health Tax, ... in 2009WASHINGTON, May 28 The so-called "hidden ... in 2008 according to a report released today by the ...
... PhD, is the winner of the third annual Liu Young ... providing support for a young scientist on the LA BioMed ... 2005 after receiving his PhD in microbiology, immunology and molecular ... and completing a postdoctoral fellowship in tumor immunology at UCLA ...
... 28 The UltraPulse CO2 fractional laser was featured ... exciting and revolutionary new treatment for scars. During the ... as infants told their personal story and discussed recent ... treatments with the groundbreaking ActiveFX and DeepFX technologies, the ...
... platform enables payors to compete like never before ... 28 HealthEdge, provider of the only modern, ... that it will be demonstrating the award-winning HealthRules ... conference in San Diego on June 3-5. ...
... 3 to 5 hours sleep per night, study shows, , , THURSDAY, ... is getting the recommended eight hours of sleep each night. ... of highly-caffeinated energy drinks, according to new research. , And, ... polled reported falling asleep in school at least twice ...
... service to journalists and other critical audiences around ... related news releases from participating companies issued via ... for this event.(Logo: http://www.newscom.com/cgi-bin/prnh/20090417/NY00642LOGO ... http://www.newscom.com/cgi-bin/prnh/20000306/PRNLOGO )The 45th American Society ...
Cached Medicine News:Health News:'Hidden Health Tax' for Family Health Care Coverage Climbed to $1,017 in 2008 2Health News:'Hidden Health Tax' for Family Health Care Coverage Climbed to $1,017 in 2008 3Health News:Exciting Innovation in Burn Scar Treatment Using Lumenis(R) UltraPulse(R) Laser Treatments Revealed on the Today Show 2Health News:Exciting Innovation in Burn Scar Treatment Using Lumenis(R) UltraPulse(R) Laser Treatments Revealed on the Today Show 3Health News:Exciting Innovation in Burn Scar Treatment Using Lumenis(R) UltraPulse(R) Laser Treatments Revealed on the Today Show 4Health News:HealthEdge(R) to Demonstrate the Award-Winning HealthRules(R) Software Suite at AHIP Institute 2009 2Health News:Technology, Caffeine Keeping Teens Awake 2Health News:Technology, Caffeine Keeping Teens Awake 3Health News:2009 ASCO Annual Meeting and Conference News Distributed by PR Newswire Available at www.EventNewsCenter.com 2Health News:2009 ASCO Annual Meeting and Conference News Distributed by PR Newswire Available at www.EventNewsCenter.com 3
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base....
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base....
... Bench high, 26-31". Ergonomic design increases ... pnuematic control for easy height adjustment. ... allow easy mobility. Fixed footring standard. ... 5000 Volts to technical zero); ...
Inquire...
Medicine Products: